白内停品牌怎么样 申请店铺

其眼科用药尤为有名，集各类制剂、医疗器械和化学原料药等系列产品的研发、生产、销售于一体的综合性医药企业。

远大医药（远大医药（中国）有限公司，英文名称为Grand Pharmaceutical (China) Co., Ltd.）是一家拥有70多年辉煌历史的现代医药集团，前身为八路军太行山革命根据地的一个制药所，曾为抗日战争和解放战争做出巨大贡献。2002年加入中国远大集团，2008年成为母公司香港上市公司——远大医药健康控股有限公司（股票代码：HK0512）的核心企业。

远大医药目前拥有十多家成员企业，是集各类制剂、医疗器械和化学原料药于一体的综合性医药企业。公司的核心产品涵盖五官科、心血管急救制剂/器械、生物技术和特色原料药为代表的三大业务领域，形成以欣维宁为核心的心血管用药；以瑞珠和白内停为核心的眼科用药；以切诺、诺通为核心的耳鼻喉科用药；以眼表检测试纸和眼科手术耗材为核心的医疗器械；以及利用多种生物工程技术制备的氨基酸及其衍生物产品群。近年来，远大医药通过推进战略转型，转变发展方式，加快自主创新，不断拓展产品市场，经营发展整体态势良好，销售收入和利润每年保持30%以上的增长。

远大医药始终秉持“敢为人先，共享成功”的企业精神，以“提供好产品，修炼高境界”为经营理念，围绕转型升级，不断提升企业的核心业务优势，创造新的需求通过现代化管理平台和专业化技术平台，推动着企业向现代化和国际化目标迈进，努力成为受中国医生和患者尊重的制药企业。

Its ophthalmic medicine is particularly famous. It is a comprehensive pharmaceutical enterprise integrating R & D, production and sales of various preparations, medical devices and chemical raw materials. Yuanda Pharmaceutical (China) Co., Ltd., English name is grand Pharmaceutical (China) Co., Ltd.), a modern pharmaceutical group with a glorious history of more than 70 years, formerly a Pharmaceutical Institute in Taihang Mountain revolutionary base of the Eighth Route Army, has made great contributions to the Anti Japanese War and the war of liberation. In 2002, he joined China Yuanda Group, and in 2008, he became the core enterprise of Hong Kong listed parent company Yuanda pharmaceutical health Holding Co., Ltd. (Stock Code: hk0512). With more than ten member enterprises, Yuanda pharmaceutical is a comprehensive pharmaceutical enterprise integrating various preparations, medical devices and chemical APIs. The company's core products cover the three business areas represented by the Department of facial features, cardiovascular first-aid agents / devices, biotechnology and characteristic APIs, forming cardiovascular drugs with Xinweining as the core; ophthalmic drugs with Ruizhu and bainetone as the core; otolaryngology drugs with chenuo and notong as the core; medical devices with eye surface test paper and ophthalmic surgical consumables as the core; And amino acids and their derivatives produced by various bioengineering technologies. In recent years, through the promotion of strategic transformation, transformation of development mode, acceleration of independent innovation, continuous expansion of product market, good overall situation of business development, sales revenue and profit growth of more than 30% every year. Yuanda pharmaceutical always adheres to the enterprise spirit of "dare to be the first, share success", takes "provide good products, cultivate high realm" as the business philosophy, around the transformation and upgrading, continuously improves the core business advantages of the enterprise, creates new needs, through the modern management platform and professional technology platform, promotes the enterprise to move forward towards the goal of modernization and internationalization, and strives to become a recipient of Chinese medicine Pharmaceutical companies with respect to health and patients.

本文链接： https://brand.waitui.com/d0aa3d4ad.html 联系电话：400-990-9697,027-83366677